Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

  • receive the eCopy two days prior to the printed edition.
  • can partake in our online MCQs.
  • can enter our online sports quiz. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

You are reading 1 of 2 free-access articles allowed for 30 days

INITIative launches first in a series of workshops

By Mindo - 07th Feb 2018 | 31 views

The workshop, titled ‘Infliximab therapeutic drug monitoring in clinical practice’, featured interactive discussion of clinical case studies with two visiting world experts in the field. Prof Joao Goncalves, Principal Investigator at iMed, The Research Institute for Medicines at the University of Lisbon, Portugal, presented data on the current assays available for measuring infliximab levels, from laboratory assays to point-of-care testing.

Following this, Prof Fernando Magro, Professor in Gastroenterology at Hospital de Sao Joao, Porto, Portugal, presented results from a range of studies, many led by Prof Magro, outlining the clinical evidence for therapeutic drug monitoring of biologics in gastroenterology. He also discussed latest evidence in the hotly-debated area of proactive versus reactive testing and monitoring.

The workshop, chaired by the Network’s Chair Prof Glen Doherty, also featured the launch of the 2017 annual report of INITIative.

“2017 was the second full year of operation for the INITIative Network and marked the launch of several key studies, including our first multi-centre, investigator-initiated clinical trial. The Network also conducted the first of a number of patient focus groups on research, helping to define the priority areas for future research from the perspective of patients with Crohn’s and Colitis,” said Dr Doherty.

Prof Magro, praising the success of INITIative to date, said its presence would “assist greatly in putting IBD research from Ireland on the map in Europe and throughout the world”.

INITIative was founded in 2015 in order to foster collaboration and encourage multi-centre, investigator-initiated studies in Crohn’s disease and ulcerative colitis in Ireland. See for more information.

Leave a Reply

Latest Issue
medical news
The Medical Independent 19th May 2022

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read